Clinical trial
The Effect of Infliximab in Patients With Chronic Low Back Pain and Modic Changes. A Randomized, Double Blind, Placebo-controlled, Multicenter Trial
NCT03704363 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Infliximab in Patients With Chronic Low Back Pain and Modic Changes. A Randomized, Double Blind, Placebo-controlled, Multicenter Trial
- Lead sponsor
- Oslo University Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 12, 2018
- Completion date
- September 29, 2023
- Enrollment
- 128 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.